Steven P Gelone

from Philadelphia, PA

Get Report

Also known as:

Steven Peter Gelone

Connected to:

Steven Gelone Phones & Addresses

Philadelphia, PA

Work

Company:

Viropharma incorporated
Jan 2005
Address:

Exton, PA
Position:

Vice president, global pre-clinical and clinical development

Education

Degree:

Doctor of Pharmacy (Pharm.D.)
School / High School:

Temple University School of Pharmacy
1985 to 1993
Specialities:

Pharmacy

Skills

Clinical Trials • Infectious Diseases • Medical Writing • Pharmaceutical Industry • Medical Affairs • Drug Development • Clinical Research • Ind • Clinical Operations • Clinical Pharmacology • Fda • Clinical Data Management • Protocol • Regulatory Submissions • Ctms • Biotechnology • Biopharmaceuticals • Medical Education • Gcp • Oncology • Translational Medicine • Therapeutic Areas • Nda • Pharmacy • Neurology • Diabetes • Infection • Drug Discovery • Drug Safety • Pharmacokinetics • Lifesciences • Clinical Study Design • Edc • Immunology • Internal Medicine • Endocrinology • Clinical Monitoring • Ich Gcp • Cdisc • Ectd • Pharmaceutical Research • Patient Recruitment • Trial Management • Regulatory Documentation • Publication Planning • Biologics • Drug Metabolism

Industries

Pharmaceuticals

Isbn (Books And Publications)

Pelvic Inflammatory Disease

view source

Author
Steven Gelone

ISBN #
0791085074

License Records

Steven Peter Gelone

Address:

Philadelphia, PA 19145

License #:

PI089631L - Expired

Category:

Pharmacy

Type:

Pharmacy Intern

Us Patents

Method For Treating Vulvar Vestibulitis
view source
US Patent:

61504009, Nov 21, 2000
Filed:

Dec 23, 1998
Appl. No.:

9/219975
Inventors:

Paul Nyirjesy - Rydal PA
Steven P. Gelone - Wyndmoor PA
Assignee:

Presutti Laboratories - Arlington Heights IL
International Classification:

A61K 3135
US Classification:

514456
Abstract:

The present invention provides an improved method for treating vulvar vestibulitis in a patient, comprising applying to the vestibule or the vestibule and the vagina of a patient an effective amount of a composition comprising a compound which inhibits the release of mediators from mast cells. The method is simple, inexpensive, well tolerated, and effective in the majority of cases.

Resumes

President And Chief Operating Officer

view source

Location:

Exton, PA

Industry:

Pharmaceuticals

Work:

ViroPharma Incorporated - Exton, PA since Jan 2005
Vice President, Global Pre-Clinical and Clinical Development
ViroPharma Incorporated - Exton, PA since Jan 2008
Vice President, Medical Affairs
ViroPharma Incorporated - Exton, PA since Jan 2005
Senior Director, Clinical Development and Medical Affairs
Phoenix Pharmacetuical Consulting - Wyndmoor, PA Aug 2004 - Jan 2005
Principal
Vicuron Pharmaceuticals - King of Prussia, PA Jan 2003 - Aug 2004
Director, Clinical Development and Medical Affairs

Education:

Temple University School of Pharmacy 1985 - 1993
Doctor of Pharmacy (Pharm.D.), Pharmacy

Skills:

Clinical Trials
Infectious Diseases
Medical Writing
Pharmaceutical Industry
Medical Affairs
Drug Development
Clinical Research
Ind
Clinical Operations
Clinical Pharmacology
Fda
Clinical Data Management
Protocol
Regulatory Submissions
Ctms
Biotechnology
Biopharmaceuticals
Medical Education
Gcp
Oncology
Translational Medicine
Therapeutic Areas
Nda
Pharmacy
Neurology
Diabetes
Infection
Drug Discovery
Drug Safety
Pharmacokinetics
Lifesciences
Clinical Study Design
Edc
Immunology
Internal Medicine
Endocrinology
Clinical Monitoring
Ich Gcp
Cdisc
Ectd
Pharmaceutical Research
Patient Recruitment
Trial Management
Regulatory Documentation
Publication Planning
Biologics
Drug Metabolism